High-dose sulbactam population pharmacokinetics in patients with severe carbapenem-resistant Acinetobacter baumannii infection
To study a pharmacokinetics model of sulbactam and optimal dosing regimens to achieve a time above a minimal inhibitory concentration (fT > MIC) of 50%, 75%, and 100% in patients with Carbapenem-Resistant Acinetobacter baumannii (CRAB) infection. This prospective pharmacokinetic study was conducted o...